AMPAC FINE CHEMICALS

Lobbying Spend

—

Filings

Firms Hired

Active Period

2017–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	5	1
2018	—	4	1
2017	—	3	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
LUNGREN LOPINA LLC	—	28

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	25
SENATE	25
Drug Enforcement Administration (DEA)	10
Health & Human Services, Dept of (HHS)	2
Executive Office of the President (EOP)	1
Office of the Vice President of the United States	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Pharmacy	Pharmacy	28

AMPAC FINE CHEMICALS — Lobbying Disclosure | Poliscope